Literature DB >> 29912931

Hierarchical closeness-based properties reveal cancer survivability and biomarker genes in molecular signaling networks.

Tien-Dzung Tran1, Yung-Keun Kwon2.   

Abstract

Specific molecular signaling networks underlie different cancer types and quantitative analyses on those cancer networks can provide useful information about cancer treatments. Their structural metrics can reveal survivability of cancer patients and be used to identify biomarker genes for early cancer detection. In this study, we devised a novel structural metric called hierarchical closeness (HC) entropy and found that it was negatively correlated with 5-year survival rates. We also made an interesting observation that a network of higher HC entropy was likely to be more robust against mutations. This finding suggested that cancers of high HC entropy tend to be incurable because their signaling networks are robust to perturbations caused by treatment. We also proposed a novel core identification method based on the reachability factor in the HC measure. The cores were permitted to decompose such that the negative relationship between HC entropy and cancer survival rate was consistently conserved in every core level. Interestingly, we observed that many promising biomarker genes for early cancer detection reside in the innermost core of a signaling network. Taken together, the proposed analyses of the hierarchical structure of cancer signaling networks may be useful in developing future novel cancer treatments.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29912931      PMCID: PMC6005509          DOI: 10.1371/journal.pone.0199109

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  71 in total

1.  Identification of core-periphery structure in networks.

Authors:  Xiao Zhang; Travis Martin; M E J Newman
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2015-03-06

2.  Structures of complement component C3 provide insights into the function and evolution of immunity.

Authors:  Bert J C Janssen; Eric G Huizinga; Hans C A Raaijmakers; Anja Roos; Mohamed R Daha; Kristina Nilsson-Ekdahl; Bo Nilsson; Piet Gros
Journal:  Nature       Date:  2005-09-22       Impact factor: 49.962

Review 3.  KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma.

Authors:  Jonas Cicenas; Linas Tamosaitis; Kotryna Kvederaviciute; Ricardas Tarvydas; Gintare Staniute; Karthik Kalyan; Edita Meskinyte-Kausiliene; Vaidotas Stankevicius; Mindaugas Valius
Journal:  Med Oncol       Date:  2017-01-10       Impact factor: 3.064

4.  Network information improves cancer outcome prediction.

Authors:  Janine Roy; Christof Winter; Zerrin Isik; Michael Schroeder
Journal:  Brief Bioinform       Date:  2012-12-18       Impact factor: 11.622

5.  Screening for epidermal growth factor receptor mutations in lung cancer.

Authors:  Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

6.  Synthetic lethal therapy for KRAS mutant non-small-cell lung carcinoma with nanoparticle-mediated CDK4 siRNA delivery.

Authors:  Cheng-Qiong Mao; Meng-Hua Xiong; Yang Liu; Song Shen; Xiao-Jiao Du; Xian-Zhu Yang; Shuang Dou; Pei-Zhuo Zhang; Jun Wang
Journal:  Mol Ther       Date:  2014-02-05       Impact factor: 11.454

7.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

8.  The global burden of cancer: priorities for prevention.

Authors:  Michael J Thun; John Oliver DeLancey; Melissa M Center; Ahmedin Jemal; Elizabeth M Ward
Journal:  Carcinogenesis       Date:  2009-11-24       Impact factor: 4.944

9.  Boolean network model for cancer pathways: predicting carcinogenesis and targeted therapy outcomes.

Authors:  Herman F Fumiã; Marcelo L Martins
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Cellular network entropy as the energy potential in Waddington's differentiation landscape.

Authors:  Christopher R S Banerji; Diego Miranda-Saavedra; Simone Severini; Martin Widschwendter; Tariq Enver; Joseph X Zhou; Andrew E Teschendorff
Journal:  Sci Rep       Date:  2013-10-24       Impact factor: 4.379

View more
  1 in total

1.  Identification of anticancer drug target genes using an outside competitive dynamics model on cancer signaling networks.

Authors:  Tien-Dzung Tran; Duc-Tinh Pham
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.